The Patient Journey: Cell and Gene Therapies
Date: Oct. 6, 2024
Time: 9:05-9:55am CT
Orsini Panelist: Kathi Henson
The panel will also include representatives from Cencora, Nebraska Medicine, and OutcomeRx.
NASP 2024
Join Orsini’s Sessions at NASP 2024
Join Orsini experts Kathi Henson and Lynda Parker at NASP 2024 to learn more about the cell and gene therapy patient journey and the state of Duchenne muscular dystrophy care. You won’t want to miss these insightful presentations, so don’t forget to add them to your schedule!
Cell and Gene Therapy Operational and Implementation Considerations for Specialty Pharmacy
Date: Oct. 6, 2024
Time: 1-1:50pm CT
Orsini Panelist: Kathi Henson
The panel will also include representatives from Cencora, Nebraska Medicine, OutcomeRx, and Vaalia Health.
State of Care: Duchenne Muscular Dystrophy
Date: Oct. 9, 2024
Time: 12:30-1:30pm CT
Presenters: Kathi Henson and Lynda Parker
The Duchenne muscular dystrophy marketplace has seen tremendous growth and change in recent years, and new advances continue to be made and new therapies approved. In tandem with these changes, the care and management of Duchenne patients has evolved as well, and specialty pharmacies must shift to meet their unique needs. This session will offer an overview of the Duchenne market, discuss innovative approaches treating and supporting to Duchenne patients, and give insights on how specialty pharmacies can manage Duchenne therapies and maintain healthy relationships with their manufacturers.
Kathi Henson, SVP, Patient Services, Nursing & Quality
